Skip to main content

Table 3 Reasons for Classification of Progressive Disease According to Criteria

From: Staging of lymphoma under chimeric antigen receptor T-cell therapy: reasons for discordance among imaging response criteria

Criteria

TL PD

Focality of

Progressive Lesions

NTL PD

NL PD

New Organ Lesion

PMD

Uni

Oligo

Multi

Total

Nodal

Extra-nodal

Both

Lugano

10

4

1

5

3

7

2

1

4

Bone (3)

Muscle (3)

Peritoneal (2)

Fat tissue

Kidney

Liver

Lung

Pancreas

Pleura

2

Cheson

10

4

1

5

3

7

2

1

4

0

RECIL

7

1

1

5

0

7

2

1

4

0

LYRIC

6

0

1

5

1

6

1

1

4

0

  1. Comparison of different imaging response criteria and the reasons for progressive disease. Shown are patient numbers with uni, oligo or multi target lesion (TL) progression, non-target lesion (NTL) progression, appearance of new lesions (NL) and progressive metabolic disease (PMD). Overlap of progression by multiple causes occurred in 53.8% of progressive patients by Lugano criteria, in 54.5% of patients by Cheson criteria, in 57.1% by RECIL, and 85.7% by LYRIC.